Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jintangning Capsule is an approved traditional Chinese medicine (TCM) formulation developed and marketed by Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. It is specifically indicated for the treatment of type 2 diabetes mellitus in patients exhibiting TCM symptom patterns characterized by dampness and blood stasis, including abdominal fullness, fatigue, limb numbness, and pain. The formulation is composed of active herbal ingredients, notably *Faeces Bombycis* (silkworm excrement) and *Radix Glycyrrhizae* (licorice root). Its therapeutic actions are described in TCM terms as eliminating dampness, invigorating blood circulation, and relieving pain. The product is administered as an oral capsule containing brownish-yellow grains or powder.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jintangning Capsule.